Hyaluronic acid filler using microneedle patch
AssigneeLG Household & Health Care Ltd.
InventorsJun-Seok Yeom, Woo-Sun Shim, Young-Min Hwang, Seung-Min Yoo, Seol-Hoon Lee, Nae-Gyu Kang
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a soluble microneedle and a filler composition with an excellent anti-wrinkle effect. Using the microneedle according to the present disclosure, crosslinked hyaluronic acid (hyaluronic acid filler material) can be intradermally or subcutaneously administered by a simple method, and a swelling property of the crosslinked hyaluronic acid is improved after administration, thereby exhibiting the excellent anti-wrinkle effect.
Claims18
A soluble microneedle for delivering filler particles into skin comprising:
- (i) a material forming a soluble microneedle comprising a mixture of oligo hyaluronic acid, sodium carboxymethyl cellulose (Na-CMC) and a plasticizer;
- and
- (ii) a plurality of filler particles comprising crosslinked hyaluronic acid and trehalose,
- wherein the molecular weight of the crosslinked hyaluronic acid is 100,000 to 5,000,000, and is comprised in an amount of 0.01 to 40% by weight based on the total weight of the microneedle,
- wherein the trehalose is comprised in an amount of 0.05 to 10% by weight based on the total weight of the plurality of filler particles,
- wherein the trehalose and the crosslinked hyaluronic acid are comprised at a weight ratio of 1:0.0001 to 0.1 (trehalose:crosslinked hyaluronic acid),
- wherein the soluble microneedle is formed from a microneedle solution consisting of the oligo hyaluronic acid, the Na-CMC, the plasticizer, the crosslinked hyaluronic acid, the trehalose, and water,
- wherein the filler particles are impregnated in the material forming the soluble microneedle;
- wherein the filler particles are adapted to be delivered when the material forming a soluble microneedle dissolves after the microneedle is applied into skin;
- and
- wherein the crosslinked hyaluronic acid in the filler particles are adapted to be swelled after intradermal or subcutaneous delivery of the filler particles.
Dependencies are inferred from the claim text.